Pal'chykovs'ka L H, Vasyl'chenko O V, Platonov M O, Kostina V H, Lysenko N A, Aleksieieva I V, Hovorun D M, Shved A D
Ukr Biokhim Zh (1999). 2011 Mar-Apr;83(2):65-73.
A convenient method of synthesis was developed and two series of N-arylamides of 9-methyl- and 9-methoxyphenazine-1-carboxylic acids were obtained. By the molecular docking method the mode of the synthesized compounds interaction with catalytic pocket of the RNA polymerase T7 transcription complex was simulated. Key ligand-receptor intermolecular contacts were identified. They are realized by various types of non-covalent interactions with line of conservative amino acid residues involved in recognition of incoming nucleotide, catalytic act of RNA synthesis as well as in stabilizing the RNA-DNA hybrid at early steps of transcription. In silico data indicate sufficient affinity of ligands for the receptor and allow to predict their ability to inhibit the functioning of RNA polymerase T7 transcription complex that is consistent with preliminary experimental results. Initial testing in a model RNA polymerase T7 transcription system demonstrates significant inhibition of in vitro RNA synthesis by investigated compounds at a concentration of 25 microg/ml (approximately 80 microM).
开发了一种简便的合成方法,得到了两个系列的9-甲基-和9-甲氧基吩嗪-1-羧酸的N-芳基酰胺。通过分子对接方法模拟了合成化合物与RNA聚合酶T7转录复合物催化口袋的相互作用模式。确定了关键的配体-受体分子间接触。它们通过与参与识别进入核苷酸、RNA合成催化作用以及在转录早期稳定RNA-DNA杂交体的保守氨基酸残基的各种非共价相互作用来实现。计算机模拟数据表明配体对受体具有足够的亲和力,并允许预测它们抑制RNA聚合酶T7转录复合物功能的能力,这与初步实验结果一致。在模型RNA聚合酶T7转录系统中的初步测试表明,所研究的化合物在浓度为25微克/毫升(约80微摩尔)时对体外RNA合成有显著抑制作用。